A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

PHASE2RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2040

Conditions
Dry Age-related Macular DegenerationGeographic Atrophy
Interventions
DEVICE

Surgical implantation of the CPCB-RPE1 implant

Surgical implantation of the CPCB-RPE1 implant

Trial Locations (5)

60439

NOT_YET_RECRUITING

University Retina, Lemont

77384

NOT_YET_RECRUITING

Retina Consultants of Texas, The Woodlands

90033

RECRUITING

USC - Keck, Los Angeles

90211

NOT_YET_RECRUITING

Retina-Vitreous Associates Medical Group, Beverly Hills

92647

RECRUITING

Retina Associates of Southern California, Huntington Beach

All Listed Sponsors
collaborator

California Institute for Regenerative Medicine (CIRM)

OTHER

lead

Regenerative Patch Technologies, LLC

INDUSTRY